Elevation Oncology, Inc. (ELEV)
NASDAQ: ELEV · Real-Time Price · USD
0.2598
-0.0002 (-0.08%)
Mar 31, 2025, 10:59 AM EDT - Market open
Elevation Oncology Market Cap
Elevation Oncology has a market cap or net worth of $15.38 million as of March 31, 2025. Its market cap has decreased by -92.42% in one year.
Market Cap
15.38M
Enterprise Value
-46.65M
1-Year Change
-92.42%
Ranking
Category
Stock Price
$0.26
Market Cap Chart
Since the IPO on June 25, 2021, Elevation Oncology's market cap has decreased from $365.16M to $15.38M, a decrease of -95.79%. That is a compound annual growth rate of -56.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 15.40M | -53.71% |
| Dec 31, 2024 | 33.26M | 46.03% |
| Dec 29, 2023 | 22.78M | 2.97% |
| Dec 30, 2022 | 22.12M | -84.16% |
| Dec 31, 2021 | 139.65M | -61.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |